Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 27 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Hypnotherapy significantly improves symptoms in IBS patients

Hypnotherapy significantly improves quality of life in irritable bowel syndrome patients, both in the short- and long-term, claim British researchers reporting to the BSG conference.

News image

fiogf49gjkf04

Two research teams investigated the impact of hypnotherapy on quality of life in patients suffering from irritable bowel syndrome (IBS).

They presented their findings at the British Society of Gastroenterology Annual Meeting in Birmingham, England.

In the first study, investigators from the Western General Hospital in Edinburgh, Scotland, evaluated the impact of gut-directed hypnotherapy upon health-related quality of life (HRQoL) status in IBS patients.

A total of 75 IBS patients (55 females, median age 37 years) were enrolled in the trial.

The predominant symptoms among the patients were abdominal pain in 46 (61%), altered bowel habit in 24 (32%), and abdominal bloating in 5 (7%).

Hospital Anxiety and Depression Scales, and an IBS disease-specific quality of life tool (IBSQoL) were used to measure outcomes.

The researchers took measurements at baseline (pre-treatment) and at 3 months post-treatment.

There were found to be statistical improvements in all domains of the IBSQoL (emotional, mental, and physical health, sleep, energy, diet, and social and physical role) after treatment.

Improvements were most marked in female patients, particularly those with predominant abdominal pain.

Furthermore, significant improvements were seen in both males and females for anxiety and depression.

Dr G. D. Smith commented that gut-directed hypnotherapy had a very positive impact upon psychological well being and HRQoL in IBS.

This appeared most effective in patients with a predominant symptom of abdominal pain and bloating.

The authors recommended that a randomized, controlled study of hypnotherapy in IBS should be conducted.

Hypnotherapy improved symptoms and quality of life in IBS patients.
BSG
In the second study, a team from the University Hospital of South Manchester, England, conducted a long-term follow-up of IBS patients treated with hypnotherapy.

A total of 239 IBS patients, who had undergone hypnotherapy between 1 and 5 years previously, were contacted and asked to complete 3 separate questionnaires. Of these, 178 patients responded.

In a Subjective Assessment Questionnaire (assessing effects of hypnotherapy, medication use, and consultation rates) 86% of patients were found to have improved at the end of hypnotherapy (62% of whom rated symptoms as very much better).

Of the patients that improved, 83% reported that, since finishing hypnotherapy, symptoms had remained the same as at the end of hypnotherapy, or had continued to improve. However, 17% had some deterioration.

In addition, 59% of patients did not require any medication. Of those who did, 40% took it less often than previously.

Three quarters of the patients consulted their GP and/or hospital consultant less often about IBS symptoms, and 49% less about other symptoms.

All IBS measures in an IBS Questionnaire (rating severity of symptoms and QOL) remained significantly better at follow-up than before hypnotherapy. These included pain severity and frequency, bloating, bowel habit dissatisfaction, and life interference.

There was only slight deterioration in some of the measures at follow-up, compared with post-hypnotherapy.

Extra-colonic symptoms, QOL, and Hospital Anxiety and Depression scores all remained improved at follow-up.

Author W. M. Gonsalkorale said on behalf of the group, "This study confirms the long-term benefit of hypnotherapy."

"In addition, the substantial reduction of medication and consultation rates highlights the significant economic advantages of this form of treatment," it was concluded.

BSG
19 March 2002

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us